Medical CE & FDA Regulatory FAQ: Compliance Standards for CAPA Report Due Diligence

Overview

As a B2B medical aesthetic device technical support engineer, I frequently receive due diligence requests from clinic owners, dermatologists, and procurement teams ahead of device acquisition or partnership agreements. One of the most common—and most sensitive—questions is whether we can provide a redacted CAPA report for due diligence. This FAQ addresses that question alongside related compliance, confidentiality, and post-sales support topics that matter to serious aesthetic buyers.

Frequently Asked Questions

Q1: Can you provide a redacted CAPA report for our due diligence?

Yes, we can provide a redacted CAPA (Corrective and Preventive Action) report for due diligence upon execution of a mutual NDA and a formal written request. The redaction removes patient-identifiable data, employee names, internal cost figures, and proprietary supplier details while preserving the CAPA structure, root-cause methodology, corrective actions, and effectiveness verification. This allows your compliance team to assess our quality management system without compromising confidentiality or regulatory obligations.

Q2: What compliance standards govern your CAPA and quality management system?

Our quality management system is built to ISO 13485, with device-level conformity to Medical CE and, where applicable, FDA 510(k) clearance. CAPA records are maintained under controlled document procedures that mirror the audit expectations of ISO 13485 and FDA 21 CFR Part 820. During due diligence, we typically share scope certificates, declaration of conformity, and redacted CAPA summaries rather than full internal records.

Q3: How do you protect confidential information while satisfying due diligence requests?

We protect confidential information through a tiered disclosure model: an NDA first, then a redacted document set, and finally an on-site or virtual audit under supervision if required. Redaction is applied consistently to patient data, personnel identifiers, and proprietary process parameters. This approach satisfies procurement and regulatory reviewers while preserving trade secrets and GDPR/HIPAA-aligned privacy protections.

Q4: Is a redacted CAPA report sufficient for hospital or clinic vendor qualification?

A redacted CAPA report is usually sufficient as an initial vendor qualification artifact, but it is rarely the only document required. Most hospital and clinic qualification teams also request ISO 13485 certificates, Medical CE or FDA documentation, risk management files (ISO 14971), and a quality agreement. We support these requests through a standard due diligence pack and can escalate to a full audit if your compliance framework demands it.

Q5: What post-sales technical support is included after device installation?

Post-sales technical support includes remote diagnostics, software updates, spare parts logistics, and engineer dispatch for hardware faults. Clinics receive access to a dedicated support portal, preventive maintenance schedules, and operator refresher training. Response times are defined by service-level agreements, and we maintain regional spare parts inventory to minimize downtime for high-throughput aesthetic practices.

Q6: How do you handle CAPA-related device corrections or field safety notices?

CAPA-related corrections and field safety notices are handled through a documented vigilance procedure that includes customer notification, corrective action tracking, and effectiveness checks. If a field safety corrective action affects your device, we issue a formal notice with clear instructions, replacement parts or software, and verification of completion. Records are retained and made available in redacted form for your regulatory audits.

Q7: Can you support regulatory audits or inspections at our clinic?

Yes, we support regulatory audits and inspections at your clinic with documentation, remote technical experts, and, if needed, on-site representation. Our regulatory affairs team can provide redacted CAPA evidence, training records, and device history records that align with ISO 13485 and FDA inspection expectations. We also offer mock audit support to help your team prepare.

Q8: What is the typical turnaround time for a redacted CAPA report request?

The typical turnaround time for a redacted CAPA report request is 5–10 business days after NDA execution and receipt of a written scope. Complex requests involving multiple device models or historical CAPAs may require 10–15 business days. We assign a named compliance contact to manage the request and keep your procurement timeline on track.